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Background
The pre-operative workup of orthotopic liver transpan-
tation (OLT) patents is practically complex given the
need for separate cardiac, vascular, and abdominal ima-
ging. Precise diagnosis and staging of hepatocellular car-
cinoma (HCC) is crucial in the selection and timing
orthotopic liver transplantation (OLT) in cirrhotic pts.
We have recently demonstrated in our ‘Proof of Con-
cept’ study in determining the short term value of a
‘One Stop Shop’ approach combining the attributes of a
nuclear stress, echocardiogram and abdominal MRI into
one single, same day, pre-op CMR evaluation. However,
this approach requires further validation, as detection of
HCC as well as cardiovascular risk assessment is criti-
cally important in these pts. We hypothesize in this
intermediate term and larger study that CAD assess-
ment and HCC detectability is independent of whether
the study is performed as part of a larger One Stop
Shop CMR or as a traditional focused MRI.
Methods
In this observational study, patients underwent SSFP
sequences, stress CMR, thoracoabdominal MRA, and
abdominal MRI on a standard MRI scanner on a single
day while a matched cohort underwent standard sepa-
rate MRI, Echocardiography and Nuclear stress testing
over a 2-3 day protocol. CMR Pharmacological stress
test was performed using vasodilators or dobutamine.
Results
Over 6 years, 218 consecutive liver transplant candidates
(mean age 58 ± 9 years, 40% female, mean MELD
score:16 ± 8; range: 6-40) underwent 289 pre-op evalua-
tions in the cardiac MRI suite. All referred pts com-
pleted standard dynamic CMR, 89% completed stress
CMR, 89% completed LGE for viability, 88% completed
liver MRI and 88% completed MRA. The mean duration
of the entire study was 72∫ ± 5 min while 91%of pts
were able to complete the entire exam. Among all
218 patients, 12 required follow-up coronary angiogra-
phy due to abnormal CMR (4 patients had significant
ischemia and required intervention, one had moderate
AS). A total of six pts underwent RHC to evaluate pul-
monary hypertension based on cardiac MRI findings
and were found to have mild to moderate PH. A total of
38 (17%) pts proceeded to OLT. There were 53 (24%)
ascertained mortalities in the non-transplant group and
6 deaths in the transplanted group; non from CAD.
Explant pathology confirmed/exclusion of HCC in
explanted livers; 98% detected on liver MRI but not in
1 pt who had HCC lesions that were ≤ 2 mm. No com-
plications during CMR examination were encountered.
Conclusions
Our study confirms that CMR evaluation of the liver
along with cardiac evaluation is equivalent to traditional
testing for the detection of HCC lesions as well as add-
ing a pre-operative cardiac risk evaluation supplanting
the need for separate Echocardiography and Nuclear
stress testing. This is an important next step towards
the long-term validation of the CMR One-Stop-Shop
concept for pre-op evaluation for potential liver trans-
plant patients improving patient throughput and satis-
faction while eliminating radiation and reducing total
costs.
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